You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VV's

Showing 1 - 25 of 778
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial (VV119(SAD), VV119 Placebo(SAD), VV119(FE))

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Oct 23, 2023

Conversion From Vv-ECMO to Va-ECMO in COVID-19 Patients

Not yet recruiting
  • ARDS Due to Disease Caused by SARS Co-V-2
  • Conversion from vv-ECMO to va-ECMO
  • (no location specified)
Jun 27, 2023

Healthy Subjects Trial in Shanghai (Deuremidevir Hydrobromide for Suspension 100mg, Deuremidevir Hydrobromide for Suspension

Not yet recruiting
  • Healthy Subjects
  • Deuremidevir Hydrobromide for Suspension 100mg
  • +3 more
  • Shanghai, Shanghai, China
    Huashan Hospital affiliated to Fudan University
Jun 30, 2023

Quality of Life 1y and 2 y After VV-ECMO for COVID-19

Recruiting
  • COVID-19 Acute Respiratory Distress Syndrome
  • +3 more
  • VV-ECMO
  • Ghent, Belgium
    Ghent university hospital
Mar 21, 2023

Different VV ECMO Flows on Lung Perfusion Monitored by EIT

Recruiting
  • Critical Illness
    • Wuhan, Hubei, China
      Xiaobo Yang
    Mar 18, 2023

    Intravenous Continuous LMWH Seems to be Safe Alternative to UFH

    Completed
    • Refractory Respiratory Failure
    • No intervention, just retrospective analysis of data.
    • Prague, Czechia
      Unoversity Hospital Motol, Department of Anaesthesiology and Int
    Aug 22, 2023

    Healthy Subjects Trial in Shanghai (VV116 25mg Group, VV116 200mg Group, VV116 400mg Group)

    Completed
    • Healthy Subjects
    • VV116 25mg Group
    • +4 more
    • Shanghai, Shanghai, China
      Shanghai Xuhui Central Hospital
    May 31, 2022

    Mild to Moderate COVID-19 Trial in China (JT001, Placebo)

    Recruiting
    • Mild to Moderate COVID-19
    • Fuzhou, Fujian, China
    • +8 more
    Nov 17, 2022

    Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.

    Not yet recruiting
    • Ards
    • +2 more
    • No applicable
    • (no location specified)
    Aug 12, 2022

    Healthy Subjects Trial in Shanghai (VV116 200 mg Group, VV116 400mg Group, VV116 600mg Group)

    Completed
    • Healthy Subjects
    • VV116 200 mg Group
    • +2 more
    • Shanghai, China
      Shanghai Xuhui Central Hospital
    Feb 8, 2022

    Moderate to Severe COVID-19 Trial in Shanghai, Tashkent (JT001, JT001 , Favipiravir)

    Not yet recruiting
    • Moderate to Severe COVID-19
    • Shanghai, Shanghai, China
    • +1 more
    Mar 14, 2022

    Healthy Subjects Trial in Geelong, Melbourne (JT001 200mg Bid, JT001 400mg Bid, JT001 600mg Bid)

    Not yet recruiting
    • Healthy Subjects
    • JT001 200mg Bid
    • +2 more
    • Geelong, Victoria, Australia
    • +1 more
    Apr 25, 2022

    COVID-19 Trial in Shanghai (JT001, Paxlovid)

    Completed
    • COVID-19
    • Shanghai, Shanghai, China
    • +6 more
    Sep 18, 2022

    Healthy Subjects Trial in Shanghai (VV116)

    Completed
    • Healthy Subjects
    • Shanghai, China
      Shanghai Xuhui Central Hospital
    Jan 20, 2022

    Oncolytic Virotherapy Trial in St. Petersburg (Double Recombinant Vaccinia Virus VV-GMCSF-Lact)

    Recruiting
    • Oncolytic Virotherapy
    • Double Recombinant Vaccinia Virus VV-GMCSF-Lact
    • St. Petersburg, Russian Federation
      N.N. Petrov National Medical Research Center of Oncology
    May 11, 2022

    Prone Position Ventilation in Danish COVID-19 Induced Severe

    Completed
    • ARDS, Human
    • +4 more
    • Prone position ventilation
    • Aarhus, Denmark
    • +1 more
    Jan 20, 2023

    Respiratory Infection Virus, Respiratory Failure Trial (Sivelestat Sodium for Injection, The Placebo)

    Not yet recruiting
    • Respiratory Infection Virus
    • Respiratory Failure
    • Sivelestat Sodium for Injection
    • The Placebo
    • (no location specified)
    Jan 22, 2023

    Transpulmonary MP on Prognosis of Severe ARDS Treated With

    Not yet recruiting
    • Acute Respiratory Distress Syndrome
    • +3 more
    • Transpulmonary pressure
    • Beijing, Beijing, China
      Beijing Chao-Yang Hospital
    Sep 25, 2023

    COVID-19 Trial in Chengdu (VV116+SOC, SOC)

    Recruiting
    • COVID-19
    • Chengdu, Sichuan, China
      Chengdu Zenitar Biomedical Technology Co., Ltd
    Feb 3, 2023

    Mild to Moderate COVID-19 Trial in China, Hong Kong (JT001, Placebo)

    Recruiting
    • Mild to Moderate COVID-19
    • Chongqing, Chongqing, China
    • +7 more
    Apr 4, 2022

    ECMO, Heparin, Respiratory Failure Trial in Dallas (subcutaneous heparin anticoagulation)

    Recruiting
    • ECMO
    • +2 more
    • subcutaneous heparin anticoagulation
    • Dallas, Texas
      Baylor Scott & White Health research institute
    Jan 25, 2023

    ECMO-VV or VA for Severe ARDS Associated With Covid-19

    Completed
    • Covid-19
      • Strasbourg, France
        Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Un
      Oct 7, 2021

      Cerebral Blood Flow in Patients on Extracorporeal Membrane

      Recruiting
      • Extracorporeal Membrane Oxygenation Complication
      • Cerebral Circulatory Failure
      • VV-ECMO
      • Amsterdam-Zuidoost, Netherlands
        Amsterdam UMC
      Mar 21, 2022

      Airway Closure During Extracorporeal Membrane Oxygenation: The

      Recruiting
      • Acute Hypoxemic Respiratory Failure
      • Acute hypoxemic respiratory failure patients on VV-ECMO
      • Toronto, Ontario, Canada
        Toronto General Hospital
      May 16, 2022

      Early v.s. Delayed VV ECMO in Severe Respiratory Failure

      Completed
      • Acute Respiratory Failure
      • ECMO
        • (no location specified)
        Apr 23, 2021